ABNIX | OSMYX | ABNIX / OSMYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 19 years | - |
Gain YTD | 9.313 | -4.465 | -209% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 120M | 3.82B | 3% |
Annual Yield % from dividends | 0.81 | 1.08 | 75% |
Returns for 1 year | 19.08 | 5.15 | 371% |
Returns for 3 years | -28.95 | -35.13 | 82% |
Returns for 5 years | 10.53 | -14.76 | -71% |
Returns for 10 years | 15.28 | 32.70 | 47% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIOIX | 28.76 | -0.35 | -1.20% |
Morgan Stanley Inst International Opp I | |||
ARIHX | 9.05 | -0.11 | -1.20% |
Aristotle Small/Mid Cap Equity I | |||
SEHAX | 15.59 | -0.19 | -1.20% |
SEI US Equity Factor Allocation A (SIIT) | |||
AMCZX | 16.05 | -0.30 | -1.83% |
Alger Mid Cap Growth Z | |||
PBLAX | 46.18 | -0.96 | -2.04% |
Principal Blue Chip A |